Molecular profiles of small cell lung cancer subtypes: therapeutic implications

Small cell lung cancer (SCLC; accounting for approximately 13%–15% of all lung cancers) is an exceptionally lethal malignancy characterized by rapid doubling time and high propensity to metastasize. In contrast to the increasingly personalized therapies in other types of lung cancer, SCLC is still r...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwendenwein, Anna, Megyesfalvi, Zsolt, Barany, Nandor, Valko, Zsuzsanna, Bugyik, Edina, Lang, Christian, Ferencz, Bence, Paku, Sandor, Lantos, Andras, Fillinger, Janos, Rezeli, Melinda, Marko-Varga, Gyorgy, Bogos, Krisztina, Galffy, Gabriella, Renyi-Vamos, Ferenc, Hoda, Mir Alireza, Klepetko, Walter, Hoetzenecker, Konrad, Laszlo, Viktoria, Dome, Balazs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917449/
https://www.ncbi.nlm.nih.gov/pubmed/33718595
http://dx.doi.org/10.1016/j.omto.2021.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917449/
https://www.ncbi.nlm.nih.gov/pubmed/33718595
http://dx.doi.org/10.1016/j.omto.2021.02.004

Ejemplares similares